Skip to main content

Wellington Management — Portfolio, Page 9

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

276
Companies
$58.1B
Total invested
$261.7M
Avg. check
52
Industries
Biotechnology 11Health Care 8Medical 6Therapeutics 4Biopharma 4Artificial Intelligence (AI) 4+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 193216 of 276
Warby Parker
May 2025

Warby Parker is a lifestyle brand that offers designer eyewear while being a socially conscious business.

E-Commerce · New York$75.0M Post Ipo Equity
Porch Group
May 2025

Porch Group is a vertical software platform for residential environments.

Home Improvement · Seattle$134.0M Post Ipo Debt
Fore Biotherapeutics
May 2025

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Biotechnology · Philadelphia$40.2M Series D
AssetWatch
April 2025

AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.

Big Data · Westerville$75.0M Series C
Maza
April 2025

Maza is a mobile app that offers financial products and digital banking services.

Banking · Los Angeles$10.0M Series Unknown
Atsena Therapeutics
April 2025

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Biotechnology · Durham$150.0M Series C
Edgewise Therapeutics
April 2025

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Biopharma · Boulder$200.0M Post Ipo Equity
Heartflow
March 2025

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI) · Mountain View$98.0M Convertible Note
Nuvation Bio
March 2025

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Biotechnology · New York$150.0M Post Ipo Debt
Aligos Therapeutics
February 2025

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Biotechnology · San Francisco$105.0M Post Ipo Equity
PHȲND
February 2025

PHȲND is a subscription-free cloud gaming platform for Smart TVs.

Business Development · Stamford$10.0M Seed
Butterfly Network
January 2025

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Artificial Intelligence (AI) · Burlington$75.6M Post Ipo Equity
Helicore Biopharma
January 2025

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Biopharma · San Mateo$65.0M Series A
Orennia
January 2025

Orennia is a technology company focused on the renewable power sector.

Analytics · CalgarySeries C
Rokt
January 2025

Rokt is an ecommerce marketing technology that enhances the value of transactions through personalized experiences.

B2B · New York$335.0M Secondary Market
Thoras.ai
January 2025

Thoras.ai is an AI cloud management platform that provides ML technology to detect symptoms for downtime prevention.

Artificial Intelligence (AI) · San Francisco$5.0M Seed
SiteOne Therapeutics
December 2024

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

Biotechnology · South San Francisco$100.0M Series C
nChroma Bio
December 2024

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Biotechnology · Boston$75.0M Series Unknown
AMP
December 2024

AMP utilizes AI-powered sortation to enhance recycling efficiency and reduce costs.

Artificial Intelligence (AI) · Louisville$91.0M Series D
Wiz
November 2024

Wiz is a cloud security platform that facilitates collaboration between security, dev, and DevOps teams.

Cloud Security · New YorkSeries Unknown
Metsera
November 2024

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Biopharma · New York$215.0M Series B
Beta Bionics
November 2024

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Biotechnology · Irvine$60.0M Series E
Ventyx Biosciences
September 2024

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Biopharma · San Diego$27.0M Post Ipo Equity
Trace Machina
August 2024

Trace Machina is a company that specializes in the development and maintenance of simulation infrastructure.

IT Infrastructure · Palo Alto$4.7M Seed

Where Wellington Management invests

Biotechnology11
Health Care8
Medical6
Therapeutics4
Biopharma4
Artificial Intelligence (AI)4

About Wellington Management's portfolio

How many companies has Wellington Management invested in?

Wellington Management has invested in 276 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?

Wellington Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 52 different industry categories.

What is Wellington Management's largest investment?

Among tracked funding rounds, Rokt received $335.0M in a Secondary Market round. Wellington Management's total known invested capital is $58.1B.

What is the average investment size for Wellington Management?

Wellington Management's average investment size is $261.7M across its portfolio of 276 companies.

What are Wellington Management's most recent investments?

Recent Wellington Management portfolio additions include Warby Parker, Porch Group, Fore Biotherapeutics, AssetWatch, Maza. These companies were founded in 2020 or later.

Reach the founders behind these 276 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →